Pedrosa Vanessa, Pontes Antônio, Pontes Paulo, Behlau Mara, Peccin Stella Maria
Departamento de Medicina, Universidade Federal de São Paulo UNIFESP, São Paulo, Brazil; Departamento de Medicina, Centro de Estudos da Voz, São Paulo, Brazil.
Departamento de Medicina, Universidade Federal de São Paulo UNIFESP, São Paulo, Brazil.
J Voice. 2016 May;30(3):377.e11-9. doi: 10.1016/j.jvoice.2015.03.013. Epub 2015 May 7.
To evaluate the effectiveness of the Comprehensive Voice Rehabilitation Program (CVRP) compared with Vocal Function Exercises (VFEs) to treat functional dysphonia.
This is a randomized blinded clinical trial.
Eighty voice professionals presented with voice complaints for more than 6 months with a functional dysphonia diagnosis. Subjects were randomized into two voice treatment groups: CVRP and VFE. The rehabilitation program consisted of six voice treatment sessions and three assessment sessions performed before, immediately after, and 1 month after treatment. The outcome measures were self-assessment protocols (Voice-Related Quality of Life [V-RQOL] and Voice Handicap Index [VHI]), perceptual evaluation of vocal quality, and a visual examination of the larynx, both blinded.
The randomization process produced comparable groups in terms of age, gender, signs, and symptoms. Both groups had positive outcome measures. The CVRP effect size was 1.09 for the V-RQOL, 1.17 for the VHI, 0.79 for vocal perceptual evaluation, and 1.01 for larynx visual examination. The VFE effect size was 0.86 for the V-RQOL, 0.62 for the VHI, 0.48 for the vocal perceptual evaluation, and 0.51 for larynx visual examination. Only 10% of the patients were lost over the study.
Both treatment programs were effective. The probability of a patient improving because of the CVRP treatment was similar to that of the VFE treatment.
评估综合嗓音康复计划(CVRP)与嗓音功能训练(VFE)治疗功能性发声障碍的有效性。
这是一项随机双盲临床试验。
80名有嗓音问题且功能性发声障碍诊断超过6个月的嗓音专业人士。受试者被随机分为两个嗓音治疗组:CVRP组和VFE组。康复计划包括六次嗓音治疗课程以及在治疗前、治疗后立即和治疗后1个月进行的三次评估课程。结果测量采用自我评估方案(嗓音相关生活质量[V-RQOL]和嗓音障碍指数[VHI])、嗓音质量的感知评估以及喉部的可视检查,均为双盲。
随机分组过程在年龄、性别、体征和症状方面产生了可比的组。两组的结果测量均为阳性。CVRP组在V-RQOL方面的效应大小为1.09,VHI方面为1.17,嗓音感知评估方面为0.79,喉部可视检查方面为1.01。VFE组在V-RQOL方面的效应大小为0.86,VHI方面为0.62,嗓音感知评估方面为0.48,喉部可视检查方面为0.51。在研究过程中仅有10%的患者失访。
两种治疗方案均有效。患者因CVRP治疗而改善的概率与VFE治疗相似。